Company Overview of Senex Biotechnology, Inc.
Senex Biotechnology, Inc. engages in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases. The company offers SNX2 non-cytotoxic molecules compounds that are developed against viral diseases, age-associated diseases, and as add-ons to existing anticancer drug regimens; and SNX9 cyclin-dependent kinase inhibitor pathway inhibitors that are developed for cancer treatment. It offers therapeutic agents to treat cancer and a range of diseases associated with the aging process, such as Alzheimer’s disease, renal disease, atherosclerosis, and arthritis. The company was incorporated in 2002 and is based in Columbia, South Carolina.
715 Sumter Street
Coker Life Science Building
Columbia, SC 29208
Founded in 2002
Key Executives for Senex Biotechnology, Inc.
Similar Private Companies By Industry
|Molecular Insight Pharmaceuticals, Inc.||United States|
|Champion Investments, Inc.||United States|
|Online Disruptive Technologies, Inc.||United States|
|Histogen, Inc.||United States|
|GrayBug, LLC||United States|
Recent Private Companies Transactions
April 17, 2014
To contact Senex Biotechnology, Inc., please visit www.senexbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.